Vontobel Holding Ltd. Certara, Inc. Transaction History

Vontobel Holding Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jun 03, 2024	SELL	$12.12 - $18.19 $56,442 - $84,710	-4,657 Reduced 16.68%	23,264 $409,000
Q4 2023 Jan 29, 2024	SELL	$12.12 - $18.19 $56,442 - $84,710	-4,657 Reduced 16.68%	23,264 $409,000
Q3 2023 Jun 03, 2024	BUY	$13.9 - $19.58 $43,242 - $60,913	3,111 Added 12.54%	27,921 $405,000
Q3 2023 Oct 10, 2023	BUY	$13.9 - $19.58 $43,242 - $60,913	3,111 Added 12.54%	27,921 $405,000
Q2 2023 Jun 03, 2024	BUY	$16.89 - $24.64 $213,759 - $311,843	12,656 Added 104.13%	24,810 $451,000
Q2 2023 Jul 24, 2023	BUY	$16.89 - $24.64 $213,759 - $311,843	12,656 Added 104.13%	24,810 $451,000
Q1 2023 Jun 03, 2024	BUY	$15.9 - $24.72 $193,248 - $300,446	12,154 New	12,154 $293,000
Q1 2023 Apr 12, 2023	SELL	$15.9 - $24.72 $306,265 - $476,156	-19,262 Reduced 61.31%	12,154 $293,000
Q4 2022 Feb 14, 2023	BUY	$10.7 - $17.84 $206,103 - $343,634	19,262 Added 158.48%	31,416 $504,000
Q4 2021 Feb 14, 2022	BUY	$26.1 - $45.21 $317,219 - $549,482	12,154 New	12,154 $346,000

233

105M

26.4K

19.2K

Ticker CERT
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 159,899,008
Market Cap $1.69B
Description
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.